Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients [Phase 3]
Phase 3 clinical trial comparing nalbuphine to morphine for mucositis pain in pediatric cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Study Evaluating Venetoclax in Subjects With Hematological Malignancies [Phase 1, Phase 2]
Clinical trial update for venetoclax in hematological malignancies at phases 1 and 2; study status completed.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia [Phase 2]
An extension Phase 2 trial evaluating the safety and anti-leukemic effects of imatinib mesylate in adults with Ph+ leukemias has completed a…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Alvocidib Biomarker-driven Phase 2 AML Study [Phase 2]
A Phase 2, biomarker-driven trial of alvocidib in acute myeloid leukemia was terminated; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients [Phase 1, Phase 2]
Phase 1/2 trial of omacetaxine with standard induction therapy (cytarabine and idarubicin) in newly diagnosed acute myeloid leukemia; study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia [Phase 2]
Phase 2 dose optimisation study of ASLAN003 in acute myeloid leukemia completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial update for MRX2843 in relapsed/refractory acute myeloid leukemia (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia [NA]
Clinical trial update on high-throughput drug sensitivity assay and genomics-guided treatment for relapsed or refractory acute leukemia; stu…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating intensive chemotherapy with or without glasdegib or azacitidine with or without glasdegib in patients with previous…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma [Phase 2]
Phase 2 trial evaluating CD8+ memory T-cells as consolidative therapy after donor non-myeloablative hematopoietic cell transplant in leukemi…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating laboratory-treated central memory/naive CD8+ T cells for newly diagnosed or relapsed acute myeloid leukemia; th…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine [Phase 1, Phase 2]
Phase II extension study of oral rigosertib in combination with azacitidine in myelodysplastic syndrome and related conditions has completed…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies [NA]
A completed clinical trial evaluating intensity modulated total marrow irradiation (IM-TMI) for advanced hematologic malignancies, with resu…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update on Total Body Irradiation with or without Total Lymphoid Irradiation and Anti-Thymocyte Globulin in non-myeloablative h…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations [Phase 2]
Phase 2 clinical trial investigating sodium stibogluconate in myelodysplastic syndromes and acute myeloid leukemia with specific p53 mutatio…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: IA14 Induction in Young Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update for IA14 induction in young acute myeloid leukemia is reported, with the study status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Unrelated Umbilical Cord Blood (UBC)Transplantation [NA]
Clinical trial update for unrelated umbilical cord blood transplantation; the study is completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML. [Phase 2]
Phase 2 trial evaluating Aza-Ven followed by reduced toxicity conditioning regimen (MBF) as salvage therapy for refractory acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). [Phase 1]
Phase 1 study evaluating alvocidib with cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia has completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS [Phase 2]
Phase II trial update for DAC in relapsed/refractory and elderly patients with acute myeloid leukemia and myelodysplastic syndrome.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase I-II open-label trial of TL32711 in acute myeloid leukemia, myelodysplastic syndrome, and acute lymphoblastic leukemia; study terminat…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial of anti-CLL1 CAR T-cell therapy for relapsed/refractory AML; status not reported.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating aprepitant as antiemetic prophylaxis in patients with acute myeloid leukemia undergoing induction chemotherapy has …
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial assessing TAK-659 in adults with relapsed or refractory acute myeloid leukemia (AML) has been terminated; results were poste…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS [Phase 2]
Phase 2 randomized trial comparing azacitidine alone versus azacitidine with vorinostat in patients with acute myeloid leukemia or high-risk…